Atanasio Pandiella Selected Research

SAR 020106

11/2020

Checkpoint Kinase 1 Pharmacological Inhibition Synergizes with DNA-Damaging Agents and Overcomes Platinum Resistance in Basal-Like Breast Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Atanasio Pandiella Research Topics

Disease

86	Neoplasms (Cancer) 05/2022 - 01/2002
57	Breast Neoplasms (Breast Cancer) 05/2022 - 01/2002
13	Multiple Myeloma 01/2016 - 12/2003
11	Triple Negative Breast Neoplasms 03/2022 - 04/2014
7	Ovarian Neoplasms (Ovarian Cancer) 08/2019 - 06/2012
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2021 - 08/2014
4	Carcinogenesis 02/2021 - 01/2009
4	Prostatic Neoplasms (Prostate Cancer) 04/2014 - 09/2011
3	Colorectal Neoplasms (Colorectal Cancer) 11/2018 - 09/2011
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2016 - 01/2008
2	Melanoma (Melanoma, Malignant) 01/2022 - 09/2011
2	Infections 10/2021 - 06/2008
2	Lung Neoplasms (Lung Cancer) 08/2021 - 12/2017
2	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2012
2	Hepatocellular Carcinoma (Hepatoma) 08/2017 - 09/2015
2	Bone Resorption 02/2013 - 01/2012
2	Bone Diseases (Bone Disease) 01/2012 - 05/2010
2	Schizophrenia (Dementia Praecox) 07/2011 - 02/2007
2	Fibrosis (Cirrhosis) 01/2006 - 01/2004
2	Necrosis 07/2005 - 04/2002
1	Hypersensitivity (Allergy) 10/2021
1	Virus Diseases (Viral Diseases) 10/2021
1	Kidney Neoplasms (Kidney Cancer) 08/2021

Drug/Important Bio-Agent (IBA)

23	Phosphotransferases (Kinase)IBA 08/2021 - 01/2002
20	Trastuzumab (Herceptin)FDA Link 01/2022 - 08/2005
16	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2005
12	Pharmaceutical PreparationsIBA 01/2022 - 06/2006
10	NeuregulinsIBA 01/2018 - 01/2002
8	Phenobarbital (Luminal)FDA Link 05/2022 - 04/2014
8	Immunoconjugates (Immunoconjugate)IBA 03/2022 - 10/2015
7	Dasatinib (BMS 354825)FDA Link 01/2020 - 09/2010
7	Bortezomib (Velcade)FDA Link 05/2013 - 04/2005
6	tyrosine receptor (receptor, tyrosine)IBA 08/2021 - 01/2002
6	AntibodiesIBA 04/2021 - 07/2016
6	LigandsIBA 01/2021 - 08/2005
6	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 05/2005
6	Ado-Trastuzumab EmtansineIBA 01/2020 - 10/2015
6	Biological ProductsIBA 08/2019 - 02/2006
6	Protein Kinases (Protein Kinase)IBA 03/2017 - 02/2013
6	Drug CombinationsIBA 01/2015 - 02/2008
5	Mitogen-Activated Protein KinasesIBA 01/2022 - 08/2002
5	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2017
4	Imatinib Mesylate (Gleevec)FDA Link 12/2021 - 12/2003
4	UbiquitinIBA 02/2021 - 06/2013
4	Epidermal Growth Factor (EGF)IBA 06/2019 - 08/2005
4	OcoxinIBA 05/2019 - 02/2016
3	snake venom protein C activatorIBA 05/2022 - 08/2019
3	Transcription Factors (Transcription Factor)IBA 03/2021 - 09/2017
3	Proteolysis Targeting ChimeraIBA 03/2021 - 08/2019
3	EnzymesIBA 02/2021 - 04/2002
3	Paclitaxel (Taxol)FDA LinkGeneric 06/2019 - 09/2017
3	AntioxidantsIBA 05/2019 - 01/2015
3	Hormones (Hormone)IBA 01/2018 - 09/2011
3	Metalloproteases (Metalloproteinases)IBA 12/2017 - 07/2005
3	Thalidomide (Thalomid)FDA Link 01/2016 - 07/2008
3	ErbB Receptors (EGF Receptor)IBA 10/2015 - 09/2008
3	Tyrosine (L-Tyrosine)FDA Link 10/2015 - 09/2010
3	Lenalidomide (CC 5013)FDA Link 05/2013 - 12/2008
3	Tyrosine Kinase InhibitorsIBA 09/2011 - 06/2009
2	MTOR InhibitorsIBA 01/2022 - 06/2012
2	XMD 8-92IBA 01/2022 - 09/2015
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2022 - 06/2012
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022 - 07/2019
2	AntigensIBA 09/2021 - 01/2019
2	IntegrinsIBA 06/2021 - 01/2020
2	Peptides (Polypeptides)IBA 02/2021 - 06/2008
2	Estrogen ReceptorsIBA 02/2021 - 01/2019
2	pertuzumabIBA 01/2021 - 08/2018
2	Checkpoint Kinase 1IBA 11/2020 - 11/2017
2	RNA (Ribonucleic Acid)IBA 08/2020 - 01/2011
2	Lapatinib (GW572016)FDA Link 01/2020 - 01/2015
2	SolutionsIBA 05/2019 - 01/2015
2	Lysine (L-Lysine)FDA Link 01/2019 - 01/2018
2	Messenger RNA (mRNA)IBA 01/2019 - 01/2014
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018 - 09/2008
2	Ubiquitin-Conjugating EnzymesIBA 01/2018 - 12/2017
2	NaphthoquinonesIBA 01/2018 - 01/2017
2	Matrix Metalloproteinases (MMPs)IBA 12/2017 - 04/2011
2	src-Family KinasesIBA 09/2017 - 09/2011
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2015 - 07/2007
2	human ERBB2 proteinIBA 11/2014 - 07/2007
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2014 - 09/2010
2	AndrogensIBA 04/2014 - 09/2012
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2014 - 09/2010
2	PM 00104IBA 05/2011 - 04/2009
2	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2011 - 05/2005
2	PanobinostatIBA 05/2010 - 06/2006
2	Dexamethasone (Maxidex)FDA LinkGeneric 05/2010 - 07/2008
2	Peptide Hydrolases (Proteases)FDA Link 07/2005 - 04/2002
1	Everolimus FDA Link 01/2022
1	Cyclin-Dependent Kinase Inhibitor p21IBA 01/2022
1	GalactosidasesIBA 01/2022
1	Cytotoxins (Cytolysins)IBA 12/2021
1	Hemagglutinins (Hemagglutinin)IBA 10/2021
1	Green Fluorescent ProteinsIBA 10/2021
1	Blocking AntibodiesIBA 08/2021

Therapy/Procedure

33	Therapeutics 03/2022 - 02/2006
9	Drug Therapy (Chemotherapy) 02/2021 - 05/2011
5	Immunotherapy 08/2021 - 01/2017
3	Neoadjuvant Therapy 02/2021 - 01/2019